SELLAS Life Sciences
16 hedge funds and large institutions have $1.33M invested in SELLAS Life Sciences in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
85% more capital invested
Capital invested by funds: $720K → $1.33M (+$615K)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
7% more funds holding
Funds holding: 15 → 16 (+1)
0.6% more ownership
Funds ownership: 6.19% → 6.79% (+0.6%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$87.9K |
| 2 |
Renaissance Technologies
New York
|
+$39K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$29.2K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$86.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$34K |
| 3 |
WG
Winton Group
London,
United Kingdom
|
-$18.4K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$2K |
SLS Hedge Fund Activity: Q2 2020 in Review
16 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in SELLAS Life Sciences (SLS) for Q2 2020, worth a combined $1.33M — up 85% from $720K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SLS positions and 4 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Squarepoint, opening a new position worth an estimated $87.9K. The largest seller was Morgan Stanley, cutting an estimated $86.3K.
- 16 institutional investors held SELLAS Life Sciences (SLS) as of Q2 2020, up from 15 in Q1 2020.
- Funds reported $1.33M of SELLAS Life Sciences stock for Q2 2020, up 85% quarter-over-quarter.
- 5 funds opened new SELLAS Life Sciences positions in Q2 2020 and 4 closed out, a net change of +1 holder.
- The largest SELLAS Life Sciences buyer in Q2 2020 was Squarepoint, an estimated $87.9K added.
- The largest SELLAS Life Sciences seller in Q2 2020 was Morgan Stanley, an estimated $86.3K sold.
Based on aggregated 13F filings for Q2 2020.